Meghan Scanlon - Jun 24, 2021 Form 4 Insider Report for BOSTON SCIENTIFIC CORP (BSX)

Role: SVP,Pres,Urology Pelvic Health
Signature: /s/ Vance R. Brown, Attorney-in-fact
Stock symbol: BSX
Transactions as of: Jun 24, 2021
Transactions value $: -$440,367
Form type: 4
Date filed: 6/28/2021, 04:18 PM
Next filing: Jul 6, 2021

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BSX	Common Stock	Options Exercise	$284K	+16.5K	+92.26%	$17.26	34.3K	Jun 24, 2021	Direct	F1
transaction	BSX	Common Stock	Sale	-$724K	-16.5K	-47.99%	$44.03	17.8K	Jun 24, 2021	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	BSX	Stock Option (Right to Buy)	Options Exercise	$0	-16.5K	-100%	$0.00^*	0	Jun 24, 2021	Common Stock	16.5K	$17.26	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan.
F2	Grant to the reporting person of an option to purchase 18,450 shares of common stock vesting in four equal annual installments beginning on February 22, 2017, the first anniversary of the date of grant.